Revance Therapeutics
Presença
Revance Therapeutics é uma das ...
Revance Therapeutics é uma empresa listada sob o símbolo RVNC (US).
Executivos
Veja o organograma con seus 19 executivos principais
Biografias mais buscadas da Revance Therapeutics
- Mark Foley, President, Chief Executive Officer and Director
- Chris Nolet, Director
- Carey O'Connor Kolaja, Director
Recentes movimentos de executivos em Revance Therapeutics
- Erica Jordan antes Senior Vice President Commerical Strategy, foi promovido a Chief Commercial Officer, Aesthetics (Notícia publicada em 9 de novembro de 2023).
Criar um alerta
para seguir os movimentos de executivos da Revance Therapeutics.
Farmacêutica
Revance Therapeutics possui 1.865 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
- Frontier Medicines acaba de anunciar uma arrecadação de fundos de 80 milhões de dólares. (publicado em 27 de fevereiro de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Revance Therapeutics
- Revance to Release Second Quarter 2022 Financial Results on Tuesday, August 9, 2022 - Revance Therapeutics, Inc.
- Revance To Present Clinical Data on DaxibotulinumtoxinA for Injection at the 2022 TOXINS International Conference - Revance Therapeutics, Inc.
- Revance to Participate in the William Blair 42nd Annual Growth Stock Conference - Revance Therapeutics, Inc.
- Revance Reports First Quarter 2022 Financial Results, Provides Corporate Update - Revance Therapeutics, Inc.
- Revance to Release First Quarter Financial Results on Tuesday, May 10, 2022 - Revance Therapeutics, Inc.
- Revance to Present Three New Abstracts Evaluating DaxibotulinumtoxinA for Injection and Two ePosters Evaluating the RHA® Collection During the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting - Revance Therapeutics, Inc.
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Revance Therapeutics, Inc.
- Revance to Participate in the Morgan Stanley 18th Annual Global Healthcare Conference - Revance Therapeutics, Inc.
- Revance to Participate in the Wells Fargo Securities Healthcare Conference - Revance Therapeutics, Inc.
- Revance Commercial Infrastructure Established and Positioned to Launch Prestige Aesthetics Portfolio with the RHA® Collection of Dermal Fillers - Revance Therapeutics, Inc.
- View more press releases Close
Redes sociais sobre Revance Therapeutics
- Revance Therapeutics na Wikipedia, Google News e Yahoo Finance
- Revance Therapeutics na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Mark Foley 
Ligue para a Revance Therapeutics em +1 510...
